Raymond James & Associates’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$58.5M Buy
507,562
+20,527
+4% +$2.15M 0.04% 401
2024
Q2
$46.3M Buy
487,035
+19,051
+4% +$1.72M 0.03% 432
2024
Q1
$38.7M Buy
467,984
+957
+0.2% +$79.2K 0.03% 487
2023
Q4
$41.1M Sell
467,027
-17,461
-4% -$1.43M 0.03% 451
2023
Q3
$41.5M Buy
484,488
+10,046
+2% +$909K 0.03% 408
2023
Q2
$44.3M Buy
474,442
+5,387
+1% +$507K 0.04% 393
2023
Q1
$46.8M Buy
469,055
+18,842
+4% +$1.92M 0.04% 379
2022
Q4
$44.6M Buy
450,213
+12,081
+3% +$1.17M 0.04% 381
2022
Q3
$38.4M Buy
438,132
+231,882
+112% +$22M 0.04% 392
2022
Q2
$18.9M Sell
206,250
-33,101
-14% -$3.12M 0.02% 643
2022
Q1
$25.9M Sell
239,351
-108,315
-31% -$10.4M 0.02% 584
2021
Q4
$40.6M Buy
347,666
+18,223
+6% +$2.14M 0.03% 447
2021
Q3
$37.3M Buy
329,443
+38,729
+13% +$4.18M 0.03% 443
2021
Q2
$25.9M Buy
290,714
+20,910
+8% +$1.96M 0.02% 581
2021
Q1
$26.3M Buy
269,804
+6,354
+2% +$596K 0.03% 540
2020
Q4
$23.7M Buy
263,450
+76,770
+41% +$6.12M 0.03% 545
2020
Q3
$13.4M Buy
186,680
+33,509
+22% +$2.66M 0.02% 711
2020
Q2
$12.4M Buy
153,171
+100,851
+193% +$7.26M 0.02% 720
2020
Q1
$3.76M Buy
52,320
+993
+2% +$72.1K 0.01% 1200
2019
Q4
$3.54M Buy
51,327
+785
+2% +$51.8K ﹤0.01% 1479
2019
Q3
$3.53M Sell
50,542
-5,874
-10% -$396K ﹤0.01% 1437
2019
Q2
$3.3M Sell
56,416
-259
-0.5% -$14.7K ﹤0.01% 1489
2019
Q1
$3.27M Buy
56,675
+1,182
+2% +$63.9K 0.01% 1451
2018
Q4
$2.81M Sell
55,493
-8,062
-13% -$404K ﹤0.01% 1435
2018
Q3
$3.41M Buy
63,555
+833
+1% +$42.7K 0.01% 1460
2018
Q2
$3.03M Buy
62,722
+462
+0.7% +$21.2K 0.01% 1494
2018
Q1
$2.45M Buy
62,260
+5,508
+10% +$208K ﹤0.01% 1582
2017
Q4
$2.02M Buy
56,752
+4,422
+8% +$162K ﹤0.01% 1686
2017
Q3
$1.93M Buy
52,330
+2,674
+5% +$88.3K ﹤0.01% 1671
2017
Q2
$1.45M Buy
49,656
+280
+0.6% +$8.37K ﹤0.01% 1795
2017
Q1
$1.47M Sell
49,376
-91,434
-65% -$2.66M ﹤0.01% 1733
2016
Q4
$4.25M Sell
140,810
-292
-0.2% -$8.47K 0.01% 1072
2016
Q3
$3.6M Sell
141,102
-16,834
-11% -$439K 0.01% 1115
2016
Q2
$4.61M Buy
157,936
+7,744
+5% +$201K 0.01% 892
2016
Q1
$3.83M Sell
150,192
-7,152
-5% -$173K 0.01% 961
2015
Q4
$3.93M Buy
157,344
+96,830
+160% +$2.46M 0.01% 919
2015
Q3
$1.35M Sell
60,514
-22
-0% -$484 0.01% 1440
2015
Q2
$1.35M Sell
60,536
-7,192
-11% -$158K 0.01% 1562
2015
Q1
$1.5M Buy
67,728
+21,160
+45% +$453K 0.01% 1415
2014
Q4
$960K Buy
46,568
+5,132
+12% +$99.5K ﹤0.01% 1607
2014
Q3
$734K Buy
+41,436
New +$761K ﹤0.01% 1678

Other funds holding EXPO

Raymond James & Associates's EXPO Position: Q3 2024 in Review

Raymond James & Associates increased its Exponent (EXPO) stake by 4.2% in Q3 2024, buying an estimated $2.15M and bringing the position to 507,562 shares worth $58.5M. The position accounts for 0.04% of the portfolio, ranked #401.

Raymond James & Associates first reported a position in EXPO in Q3 2014 and has held it in 41 quarters since. 373 funds tracked by Wall St. Rank hold EXPO as of Q3 2024.

  • Raymond James & Associates held 507,562 shares of Exponent worth $58.5M as of Q3 2024.
  • Raymond James & Associates bought 20,527 Exponent shares in Q3 2024, an estimated $2.15M.
  • Exponent made up 0.04% of Raymond James & Associates's portfolio in Q3 2024, its #401 holding.
  • Raymond James & Associates first reported a position in Exponent in Q3 2014 and has held it in 41 quarters since.
  • 373 funds tracked by Wall St. Rank held Exponent as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.